Compass Therapeutics(CMPX) - 2019 Q3 - Quarterly Report
Compass Therapeutics(CMPX)2019-11-14 06:25
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number: 000-55939 OLIVIA VENTURES, INC. (Exact name of registrant as specified in its charter) | --- | --- | |--------- ...